Allermi is formulated to treat congestion and inflammation without inducing a rebound effect.
Formulas contain a prescription-only micro-dose of oxymetazoline that is a fraction (specifically, 1/12th to 1/48th) the dosage of what is in over-the-counter oxymetazoline products such as Afrin.
At this tiny dosage, oxymetazoline gently decreases the size of capillaries in the nose, relieving the feeling of congestion and allowing the other medications in your formula better access to the high & deep reaches of the nasal passages - without the rebound.
We always combine that micro-dose of oxymetazoline with anti-inflammatory medications in the same formula, which both treats inflammation and prevents the onset of rebound.
With these two customizations, rebound congestion is not a common nor anticipated side-effect of Allermi.
If you'd like to review the data behind these conclusions, you can do so here:
https://www.allermi.com/pages/scientific-index
Learn more about tips to help deal with congestion in this article.
